INOVIO PHARMACEUTICALS, INC. (INO) Debt Components
- 2020-06-30: Long-term DebtUSD (m); Line of Credit Facility, Increase, Accrued InterestUSD (m); Long-term Debt, Fair ValueUSD (m); Debt Instrument, Interest Rate, Effective Percentagepure (m).
- 2020-03-31: Long-term DebtUSD (m); Line of Credit Facility, Increase, Accrued InterestUSD (m); Long-term Debt, Fair ValueUSD (m); Debt Instrument, Interest Rate, Effective Percentagepure (m).
- 2020-03-31: Long-term DebtUSD (m); Line of Credit Facility, Increase, Accrued InterestUSD (m); Long-term Debt, Fair ValueUSD (m); Debt Instrument, Interest Rate, Effective Percentagepure (m).
- 2019-12-31: Long-term DebtUSD (m); Line of Credit Facility, Increase, Accrued InterestUSD (m); Long-term Debt, Fair ValueUSD (m); Debt Instrument, Interest Rate, Effective Percentagepure (m).
INOVIO PHARMACEUTICALS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt USD | Line of Credit Facility, Increase, Accrued Interest USD | Long-term Debt, Fair Value USD | Debt Instrument, Interest Rate, Effective Percentage pure | Debt Instrument, Convertible, Conversion Price USD/shares | Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger pure | Debt Instrument, Convertible, Threshold Trading Days day | Debt Instrument, Convertible, Threshold Consecutive Trading Days day | Debt Instrument, Convertible, Carrying Amount of Equity Component USD | Debt Instrument, Redemption Price, Percentage pure | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | 6 month · 130.00% | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | 3 month · 130.00% | 3 month · 20.00 | 3 month · 30.00 | (m) | 3 month · 100.00% | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | 5.38 | (m) | (m) | (m) | $62.20M | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | 12 month · 130.00% | 12 month · 20.00 | 12 month · 30.00 | (m) | 12 month · 100.00% | (m) |
| 2019-12-31 | (m) | (m) | $62.20M | 13.10% | 5.38 | (m) | (m) | (m) | (m) | (m) | $18.60M |
| 2019-06-30 | $62.76M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $60.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | 12 month · $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | 12 month · $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | 9 month · $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | 12 month · $-57.19K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | 9 month · $-57.19K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | 12 month · $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | 12 month · $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | 12 month · $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | 12 month · $-61.15K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | 9 month · $-61.15K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | 6 month · $-60.82K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | 12 month · $-166.18K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |